Skip to main navigation Skip to main content

Clin Mol Hepatol : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Articles

Letter to the Editor

Clinical characteristics of portal hypertension complicated by gastroesophageal varices in patients with myeloproliferative neoplasms

Clinical and Molecular Hepatology 2020;26(1):78-82.
Published online: November 26, 2019

1The Catholic University Liver Research Center, College of Medicine, The Catholic University of Korea, Seoul, Korea

2Division of Hepatology, Department of Internal Medicine, Eunpyeong St. Mary Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea

3Division of Hematology, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea

4Division of Hepatology, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea

5Department of Hepatology, Yangon GI & Liver Center, Yangon, Myanmar

6Department of Internal Medicine, Makati Medical Center, Manila, Philippines

Corresponding author : Pil Soo Sung Division of Hepatology, Department of Internal Medicine, Eunpyeong St. Mary Hospital, College of Medicine, The Catholic University of Korea, 1021 Tongil-ro, Eunpyeong-gu, Seoul 03312, Korea Tel: +82-2-2030-2530, Fax: +82-2-3481-4025 E-mail: pssung@catholic.ac.kr
Ki-Seong Eom Division of Hematology, Department of Internal Medicine, Seoul St. Mary Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul 06591, Korea Tel: +82-2-2258-2073, Fax: +82-2-3481-4025 E-mail: dreom@catholic.ac.kr
• Received: August 25, 2018   • Accepted: September 2, 2019

Copyright © 2020 by The Korean Association for the Study of the Liver

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 11,047 Views
  • 190 Download
  • 6 Web of Science
  • 7 Crossref
  • 5 Scopus
prev

Citations

Citations to this article as recorded by  Crossref logo
  • Allogreffe de cellules souches hématopoïétiques dans la myélofibrose : sélection des patients, préparation pré-greffe et harmonisation des pratiques (SFGM-TC)
    Gaëlle Vertenoeil, Deborah Desmier, Stavroula Masouridi-Levrat, Clémence Médiavilla, Laetitia Souchet, Michael Loschi, Marie Robin, Léonardo Magro, Jérôme Cornillon
    Bulletin du Cancer.2026;[Epub]     CrossRef
  • Mielofibrosis como causa de hipertensión portal no cirrótica
    Juan José Quiroz-Leyva, Edgar Fermín Yan-Quiroz, José Richard Tenazoa-Villalobos
    Revista de Gastroenterología del Perú.2026; 46(2): 215.     CrossRef
  • Navigating ‘grey areas’ and challenges during evaluation of transplant eligibility in specific myelofibrosis populations: a perspective on behalf of the Chronic Malignancies Working Party of the EBMT
    Nicola Polverelli, Juan Carlos Hernández-Boluda, Nico Gagelmann, Carmelo Gurnari, Michele Malagola, Fernando Barroso Duarte, Vaneuza A. M. Funke, Caterina Zerbi, Donal P. McLornan
    Bone Marrow Transplantation.2025; 60(1): 10.     CrossRef
  • Role of Portosystemic Shunt and Portal Vein Stent in Managing Portal Hypertension Due to Hematological Diseases
    Ji Hoon Kim, Suho Kim, Hee-Chul Nam, Chang Wook Kim, Jae-Sung Yoo, Ji Won Han, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Ho-Jong Chun, Sung-Eun Lee, Jung-Suk Oh, Pil Soo Sung
    Cureus.2024;[Epub]     CrossRef
  • The Value of Follow‐Up Liver Stiffness Changes Measured by Virtual Touch Quantification Elastography for Predicting Recurrence of Gastroesophageal Varices after Endoscopic Injection Sclerotherapy on Cirrhotic Patients
    Yayang Duan, Jinfei Zhang, Min Fan, Derun Kong, Chaoxue Zhang, Jose Celso Ardengh
    Gastroenterology Research and Practice.2024;[Epub]     CrossRef
  • Screening for signs of portal hypertension by esophagogastroduodenoscopy in patients with BCR‐ABL negative myeloproliferative neoplasms
    Marta Davidson, Florence Wong, Mostafa Atri, Hassan Sibai, Dawn Maze, Verna Cheung, Jeannie Callum, Eshetu G. Atenafu, Vikas Gupta
    American Journal of Hematology.2023;[Epub]     CrossRef
  • Innovative strategies to improve hematopoietic stem cell transplant outcomes in myelofibrosis
    Jacinta Perram, David M. Ross, Donal McLornan, Krisstina Gowin, Nicolas Kröger, Vikas Gupta, Clinton Lewis, Nico Gagelmann, Nada Hamad
    American Journal of Hematology.2022; 97(11): 1464.     CrossRef

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

Include:

Clinical characteristics of portal hypertension complicated by gastroesophageal varices in patients with myeloproliferative neoplasms
Clin Mol Hepatol. 2020;26(1):78-82.   Published online November 26, 2019
Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:
Include:
Clinical characteristics of portal hypertension complicated by gastroesophageal varices in patients with myeloproliferative neoplasms
Clin Mol Hepatol. 2020;26(1):78-82.   Published online November 26, 2019
Close

Figure

  • 0
Clinical characteristics of portal hypertension complicated by gastroesophageal varices in patients with myeloproliferative neoplasms
Image
Figure 1. Regression of GEVs after liver transplantation in a patient with PMF. (A) Images of esophago-gastroduodenoscopy. Left panel represents the lumen of esophagus before LDLT and right panel represents after LDLT. (B) Contrast-enhanced CT scan of the abdomen. Left panel is an axial view of GEV before LDLT. Right panel is an axial view of GEV after LDLT. Arrowheads depict GEVs on CT scan. (C) H&E stained histopathological images of explant liver. Left image is a low-power view of H&E sections of the explant (H&E, ×10). Right image is a high-power field image (H&E, ×240). Scale bar 100 μm (arrowheads: myeloid metaplasia at sinusoids). GEV, gastroesophageal varices; PMF, primary myelofibrosis; LDLT, living donor liver transplantation; CT, computed tomography; H&E, Hematoxylin and eosin.
Clinical characteristics of portal hypertension complicated by gastroesophageal varices in patients with myeloproliferative neoplasms
Total patients (n=228)
PV ET PMF MPN-U
Patients 50 (21.9) 72 (31.6) 84 (36.8) 22 (9.7)
PHT by GEVs 5 (10.0) 2 (2.8) 3 (3.6) 1 (4.5)
JAK2 V617F mutation 130 (57.0)
 Positive 34 (68.0) 37 (51.4) 47 (56.0) 10 (45.5)
 Negative 16 34 37 12
 Not available 0 1 0 0
Value
Patients with PHT by GEVs (n=11, 5% of total patients)
 PV 5 (45.5)
 ET 2 (18.2)
 PMF 3 (27.3)
 MPN-U 1 (9.1)
Median age 60
Male 5 (45.5)
Anti-HCV positivity 0 (0)
HBsAg positivity 0 (0)
Portal vein thrombosis 3 (27.3)
JAK2 V617F mutation 11 (100)
Median total bilirubin (mg/dL) 1.54 (0.68–2.53)
Median albumin (g/dL) 4.3 (3.6–4.8)
Median INR 1.25 (1.15–1.60)
Treatment
 Ruxolitinib 2
 Hydroxyurea 7
Table 1. Baseline patient characteristics

Values are presented as number (%).

PV, polycythemia vera; ET, essential thrombocythemia; PMF, primary myelofibrosis; MPN-U, myeloproliferative neoplasms-unclassified; PHT, portal hypertension; GEV, gastroesophageal varices.

Table 2. Clinical characteristics of patients with PHT

Values are presented as median (range) or number (%).

PHT, portal hypertension; GEV, gastroesophageal varices; PV, polycythemia vera; ET, essential thrombocythemia; PMF, primary myelofibrosis; MPN-U, myeloproliferative neoplasms-unclassified; HCV, hepatitis C virus; HBsAg, hepatitis B surface antigen; JAK2, Janus kinase 2; INR, international normalized ratio.